Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials

Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials

Abstract Background Cardiovascular disease (CVD) is one among the major causes of mortality all round the globe. Several anti-platelet regimens have been proposed following percutaneous coronary intervention (PCI). In this analysis, we aimed to show the adverse clinical outcomes associated with tica...

Full description

Bibliographic Details
Main Authors: Chen Ning, Fang Ling, Deyi Liu, Zhang Zhi
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Cardiovascular Disorders
Subjects:
Ticagrelor monotherapy
Dual antiplatelet therapy
Diabetes mellitus
Cardiovascular events
Bleeding risk
Percutaneous coronary intervention
Online Access:https://doi.org/10.1186/s12872-024-03836-9

Internet

https://doi.org/10.1186/s12872-024-03836-9

Similar Items